Operating Company Healthcare

Averhealth

Richmond, Virginia, United States

Provider of substance use disorder monitoring and treatment solutions. Integrates monitoring (collections/electronic monitoring), laboratory services, and results reporting for court-ordered and other agency-driven programs.

Focus Areas
Substance use disorder monitoring, Court-ordered drug and alcohol testing, Electronic monitoring
Website
averhealth.com

Tracked deals

3

3 tracked deals across 2020-2021.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

2 addon · 1 divestiture

Averhealth Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Averhealth. 2 2020 1 2021

Supporting Data

Recent Transactions

  • Buyer
    Averhealth, Five Arrows Capital Partners
    Target
    Aspenti
    Type
    Addon

    Averhealth, with support from Five Arrows Capital Partners, has acquired Aspenti, a Burlington-based provider of substance use monitoring, care coordination and diagnostic services. The deal expands Averhealth's referral base into physicians, treatment centers and healthcare systems and strengthens its capabilities in population health and substance use disorder management.

  • Buyer
    Averhealth, Five Arrows Capital Partners
    Target
    American Court Services
    Seller
    Bill Parker (President and Founder), American Court Services
    Type
    Addon

    Averhealth, backed by Five Arrows Capital Partners, acquired American Court Services, a provider of court-mandated drug and alcohol testing and electronic monitoring across Ohio. The deal expands Averhealth's footprint in the Great Lakes region and adds electronic monitoring and ignition interlock capabilities to its existing substance use monitoring and treatment services.

  • Buyer
    Averhealth, Five Arrows Capital Partners
    Target
    Treatment Assessment Screening Center (TASC) (drug testing services)
    Seller
    Treatment Assessment Screening Center (TASC)

    Averhealth, with support from Five Arrows Capital Partners, acquired the drug testing services of Treatment Assessment Screening Center (TASC) of Arizona on August 28, 2020. The deal transfers TASC's drug testing operations to Averhealth, ensuring continuity of services for courts and social service agency clients and expanding Averhealth's footprint in Arizona, Texas and Utah.

Related Acquisition Pages

Selling a company? Get in front of buyers like Averhealth

Turn tracked acquisition activity into an outreach-ready buyer list.